American Gene Technologies International

United States
Barbourmeade, Kentucky, United States
301-337-2100 ★

Company profile

American Gene Technologies International company profile

American Gene Technologies (AGT) is focused on creating long-term value for patients, society, investors and donors by developing and testing cutting-edge gene therapies to cure some of humanity’s worst diseases. AGT’s HIV cure clinical trial could not only lead to a blockbuster drug that brings relief to one of society's most elusive epidemics, but it could prove the efficiency and effectiveness of AGT’s platform technologies to cure dozens of diseases ranging from viruses to cancers.

Business identity

Contact email
[email protected]
Phone number
301-337-2100
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2008-01-01

Headquarters

Headquarters
Barbourmeade, Kentucky, United States
Postal code
20850
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
6
Total equity funding
$23.2M
Last funding
Series F / 2024-08-30
Last equity funding
Series F
Investors
8
Lead investors
2
Founders
1
Articles
32

Founders and investors

Founders

Jeffrey A. Galvin

Lead investors

GaingelsRide Wave Ventures

Investors

Alumni VenturesGaingelsNational Institutes of HealthRide Wave VenturesVye Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.